Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events. | Pharmaceuticals (Basel);16(11)2023 Nov 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Biblioteca Virtual en Salud

BVS - Literatura Cientifica y Técnica

Localizar descriptor de asunto Búsqueda Avanzada

Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events.

Gu, Stephanie L; Nath, Sandy; Markova, Alina.

Gu SL; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Nath S; Urgent Care Service, Memorial Sloan Kettering Cancer, New York, NY 10065, USA.
Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Pharmaceuticals (Basel) ; 16(11)2023 Nov 15.

Article en En | MEDLINE | ID: mdl-38004475

Palabras clave

biologics; immune-related cutaneous adverse events; safety

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article